 ACTON, Mass., Aug. 30, 2022 GLOBE NEWSWIRE -- Bluejay Diagnostics, Inc. NASDAQ: BJDX Bluejay, the Company, a medical diagnostics company focused on developing cost-effective, rapid, near-patient tests for triage and monitoring of disease progression, today announced that Neil Dey, Chief Executive Officer, and Kenneth Fisher, Chief Financial Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference taking place on September 12-14, 2022, at the Lotte Palace Hotel in New York City. 